Inhomogeneous Ventilation in Adult Post-neurosurgical Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03830099 |
|
Recruitment Status : Unknown
Verified February 2019 by Jian-Xin Zhou, Capital Medical University.
Recruitment status was: Recruiting
First Posted : February 5, 2019
Last Update Posted : February 5, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Mechanical Ventilation Electrical Impedance Tomography Inhomogeneous Ventilation Neurosurgery |
| Study Type : | Observational |
| Estimated Enrollment : | 100 participants |
| Observational Model: | Other |
| Time Perspective: | Other |
| Official Title: | Inhomogeneous Ventilation in Adult Post-neurosurgical Patients: an Observational Study |
| Actual Study Start Date : | April 1, 2018 |
| Estimated Primary Completion Date : | July 31, 2019 |
| Estimated Study Completion Date : | August 31, 2019 |
- Incidence of inhomogeneous ventilation [ Time Frame: within 24 hours after neurosurgical operative ]In supine position, global image of EIT was divided into upper and lower part, each part accounting for 50%, which was named as non-dependent region and dependent region respectively. Inhomogeneous ventilation was defined as the ratio between tidal impedance variation of dependent region(VTdep) and global tidal impedance variation (VT) is less than 45% during stable Spontaneous breath, which was defined as variation of tidal volume less than 10% in continuous 6 breathes.
- The incidence of postoperative pulmonary complications(PPCs) [ Time Frame: 28 days after neurosurgical operative ]Postoperative pulmonary complication was defined as follows: Pneumonia was defined as recent pulmonary infiltration on chest radiography associated with at least 2 of the following signs: purulent tracheobronchial secretion, a body temperature > 38.3℃,and leukocytes in peripheral blood > 25% above the basal count. Tracheobronchitis was an increase in the volume or a change in the color or purulent aspect of tracheobronchial secretion with a normal chest radiograph. Atelectasis was evidence on chest radiography of pulmonary atelectasis associated with acute respiratory symptoms. Bronchoconstriction was classified as the presence of wheezing associated with acute respiratory symptoms with a good response to inhalatory bronchodilator medication.
- Length of ICU stay [ Time Frame: through study completion, an average of 7 days ]The number of days that patients stay in ICU.
- Length of hospital stay [ Time Frame: through study completion, an average of 28 days ]The number of days that patients stay in hospital.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Gender was based on basic information collected at the moment when patients was admitted to hospital. |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Undergoing elective neurosurgery operation
- Trachea intubated and mechanical ventilated
Exclusion Criteria:
- Age under 18 years-old
- Unstable hemodynamics patients (mean arterial pressure under 65mmHg) after pharmacotherapy
- History of chronic obstructive pulmonary disease(COPD) or asthma
- Contraindication of using EIT (pacemaker, defibrillator, and implantable pumps)
- Unable to install EIT belt (skin infection, wound)
- Incompleteness of thorax (e.g. pneumothorax, rib fracture and etc.) or malformation of thorax.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03830099
| Contact: Jian-Xin Zhou, MD | 8610 67096579 | zhoujx.cn@icloud.com |
| China, Beijing | |
| ICU, Beijing Tiantan Hospital, Capital Medical University | Recruiting |
| Beijing, Beijing, China, 100050 | |
| Contact: Jian-Xin Zhou, MD zhoujx.cn@icloud.com | |
| Principal Investigator: | Jian-Xin Zhou, MD | Beijing Tiantan Hospital |
| Responsible Party: | Jian-Xin Zhou, Professor, Capital Medical University |
| ClinicalTrials.gov Identifier: | NCT03830099 |
| Other Study ID Numbers: |
KY 2018-006-01 |
| First Posted: | February 5, 2019 Key Record Dates |
| Last Update Posted: | February 5, 2019 |
| Last Verified: | February 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

